October 01, 2013
1 min read
Save

ASH announces grant recipients

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The American Society of Hematology recently announced the recipients of its second round of ASH Bridge Grants.

The recipients are: Utpal P. Dave, MD, of Vanderbilt University Medical Center; Jianguo Tao, MD, PhD, of H. Lee Moffitt Cancer Center; X. Long Zheng, MD, PhD, of The Children’s Hospital of Philadelphia; Lucio H. Castilla, PhD, of the University of Massachusetts Medical School; Michael J. Thirman, MD, of the University of Chicago; Carl D. Novina, MD, PhD, of Dana-Faber Cancer Institute; Paul A. Ney, MD, of New York Blood Center; Edmund K. Waller, MD, PhD, of Emory University; Vijay M. Rao, PhD, of The University of Texas Health Science Center at Tyler; Robert F. Paulson, PhD, of The Pennsylvania State University; Seth J. Corey, MD, of Northwestern University; and Giuseppina Nucifora, PhD, of The University of Illinois at Chicago.

The grants support research of hematologists whose proposals were deemed worthy by the NIH but were not funded due to a $1.6 billion reduction in federal funding as a result of sequestration.

In July 2012, ASH committed $9 million to create the grant program to help sustain crucial blood disease research. ASH’s 1-year, $100,000 bridge grants allow basic, clinical, and translational hematology researchers whose NIH R01 series grant applications scored well but missed the funding cutoff point to continue their critical work.

“Given this harsh economic climate, instead of continuing their work searching for new treatments or cures for hematologic diseases, talented investigators who rely on NIH grants have no choice but to slow or suspend research because they no longer have the resources,” ASH President Janis L. Abkowitz, MD, of the University of Washington in Seattle, said in a press release. “This concerning trend ultimately threatens medical innovation and dissuades aspiring scientists from entering the field.”

The application deadline for the next round of bridge grants is Nov. 1. For more information, go to www.hematology.org/bridgegrants.